About
About
About
About
Code Pharma has been an established scientific research company with knowledgeable and experienced staff, committed and dedicated in the field of viral infections, AIDS and Cancer research.
We aim to bring to the market a cost-effective treatment based on findings from extensive research to the entire target demographic irrelevant of income or status.
Our ground-breaking research and patent protected findings are the basis of a new era of fighting against infectious and oncological diseases.
Code Pharma
About
Code Pharma has been an established scientific research company with knowledgeable and experienced staff, committed and dedicated in the field of viral infections, AIDS and Cancer research.
We aim to bring to the market a cost-effective treatment based on findings from extensive research to the entire target demographic irrelevant of income or status.
Our ground-breaking research and patent protected findings are the basis of a new era of fighting against infectious and oncological diseases.
Code Pharma
About
Code Pharma has been an established scientific research company with knowledgeable and experienced staff, committed and dedicated in the field of viral infections, AIDS and Cancer research.
We aim to bring to the market a cost-effective treatment based on findings from extensive research to the entire target demographic irrelevant of income or status.
Our ground-breaking research and patent protected findings are the basis of a new era of fighting against infectious and oncological diseases.
Code Pharma
About
Code Pharma has been an established scientific research company with knowledgeable and experienced staff, committed and dedicated in the field of viral infections, AIDS and Cancer research.
We aim to bring to the market a cost-effective treatment based on findings from extensive research to the entire target demographic irrelevant of income or status.
Our ground-breaking research and patent protected findings are the basis of a new era of fighting against infectious and oncological diseases.
Code Pharma
About
Code Pharma has been an established scientific research company with knowledgeable and experienced staff, committed and dedicated in the field of viral infections, AIDS and Cancer research.
We aim to bring to the market a cost-effective treatment based on findings from extensive research to the entire target demographic irrelevant of income or status.
Our ground-breaking research and patent protected findings are the basis of a new era of fighting against infectious and oncological diseases.
Code Pharma
About
Code Pharma has been an established scientific research company with knowledgeable and experienced staff, committed and dedicated in the field of viral infections, AIDS and Cancer research.
We aim to bring to the market a cost-effective treatment based on findings from extensive research to the entire target demographic irrelevant of income or status.
Our ground-breaking research and patent protected findings are the basis of a new era of fighting against infectious and oncological diseases.
Code Pharma

Code Pharma
Code Pharma is a global pharmaceutical company with knowledgeable and experienced staff, committed and dedicated in the field of viral infections, AIDS and Cancer research.We aim to bring to the market a cost-effective treatment based on findings from extensive research to the entire target demographic irrelevant of income or status.Our ground-breaking research and patent protected findings are the basis of a new era of fighting against infectious and oncological diseases.
Antiviral drug Codivir
Code Pharma is the developer of the promising antiviral drug Codivir against COVID-19. Codivir is a short synthetic 16 amino-acid peptide, derived from the HIV-1 integrase, originally discovered at the Hebrew University in Israel.
Code Pharma's team discovered that the peptide had a direct antiviral effect against SARS-CoV-2, the coronavirus causing COVID-19.In-vitro studies conducted at the British research laboratory Virology Research Services then demonstrated a potent antiviral activity against SARS-CoV-2 and other RNA viruses.

Clinical studies
Codivir is a short synthetic peptide derived from HIV virus that was found in preclinical and clinical examinations to either:
1. Leads to antiviral effect against RNA viruses.
2. Promote HIV-infected cells into self-induced death (apoptosis), and Lentivirus manipulation in the case of cancer therapy.

Our Partners



